US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

41.65

+0.01000.02%

Post-market: 41.650.00000.00%19:59 EDT

Volume:230.10K

Turnover:9.56M

Market Cap:301.96M

PE:- -

High:42.04

Open:41.84

Low:41.25

Close:41.64

52wk High:42.97

52wk Low:23.90

Shares:7.25M

Float Shares:7.25M

Volume Ratio:0.80

T/O Rate:3.17%

Dividend:0.28

Dividend Rate:0.67%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hutchmed initiates Phase Ia part of trial of HMPL-A830

EBR Systems advances FDA approval process for new WiSE manufacturing site

Incyte (INCY) Gets a Hold from Bernstein

Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (Zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva

THOMSON REUTERS

Twist Bioscience CEO Emily M. Leproust Disposes of 5,203 Common Shares Worth $921,493.96

FDA approves Incyte’s Atebrioz for fibrodysplasia ossificans progressiva

US FDA Approves Mirum's Drug for Rare Bone Disorder

FDA: Approves Atebrioz (Zilurgisertib) for Fibrodysplasia Ossificans Progressiva in Adults & Pediatric Patients 12 Years + - Website

THOMSON REUTERS

FDA : Atebrioz Recommended Dosage 100 Mg Once Daily

THOMSON REUTERS

NASDAQ New 52-Week Highs and Lows

Innovation is Driving a New Bull Market in Biotech. 16 Ways to Play It, from Our Roundtable Experts.

Moderna (MRNA) Receives a Hold from Bernstein

Vertex Minerals Sets October General Meeting for Shareholders

INLIF Stock Is Trending: Here's Why it Skyrocketed Over 93% After Hours

Benzinga Earnings

Revolution Medicines Director Elizabeth M. Anderson Disposes of $1,949,321.86 in Common Shares

Moderna Inc. Stock Advances 7.0%, Outperforms Peers

Moderna Inc Stock (MRNA) Moved Up by 5.91% on Sep 24: What Investors Need To Know

Twist Bioscience Corp Stock (TWST) Moved Up by 11.04% on Sep 24: A Full Analysis

U.S. Stocks on the MOVE-Everpure, Dropbox, Darden Restaurants

Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/IDNA/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":41.65,"timestamp":1790971200000,"preClose":41.64,"halted":0,"volume":230097,"hourTrading":{"tag":"盘后","latestPrice":41.65,"preClose":41.65,"latestTime":"19:59 EDT","volume":3094,"amount":128861.28,"timestamp":1790985596008,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.00024015369836690706,"floatShares":7250000,"shares":7250000,"eps":0,"marketStatus":"Market Closed","change":0.01,"latestTime":"10-02 16:00:00 EDT","open":41.84,"high":42.04,"low":41.25,"amount":9561511.483608,"amplitude":0.018972,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":41.64,"sharesOutstanding":5100000,"nav":41.483661,"aum":309053274.45,"dividendRate":0.006706,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":41.8183,"preClose":41.64,"latestTime":"09:24 EDT","volume":122,"amount":5156.36538,"timestamp":1790947482007,"change":0.1783,"changeRate":0.004282,"amplitude":0.028206},"postHourTrading":{"tag":"盘后","latestPrice":41.65,"preClose":41.65,"latestTime":"19:59 EDT","volume":3094,"amount":128861.28,"timestamp":1790985596008,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8041356708242576,"impliedVol":0.1282,"impliedVolPercentile":0.243},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":7250000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8041356708242576,"shares":7250000,"dividePrice":0.2793,"high":42.04,"amplitude":0.018972,"preClose":41.64,"low":41.25,"week52Low":23.9,"pbRate":"--","week52High":42.97,"institutionHeld":0,"latestPrice":41.65,"eps":0,"divideRate":0.006706,"volume":230097,"delay":0,"ttmEps":0,"open":41.84,"prevYearClose":26.19,"prevWeekClose":41.77,"prevMonthClose":42.32,"prevQuarterClose":42.32,"fiveDayClose":41.77,"twentyDayClose":40.29,"sixtyDayClose":34.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670402037","title":"Hutchmed initiates Phase Ia part of trial of HMPL-A830","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402037","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402037?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:45","pubTimestamp":1790556321,"startTime":"0","endTime":"0","summary":"Hutchmed (HCM) announces that it has initiated the Phase Ia part of a global clinical trial of HMPL-A830 in patients with unresectable, advanced or...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hutchmed-initiates-phase-ia-part-of-trial-of-hmpl-a830-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hutchmed-initiates-phase-ia-part-of-trial-of-hmpl-a830-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","HCM","BK4007","IDNA","MEDX","NVIB","BK4531","HYLG","BK4585","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402990","title":"EBR Systems advances FDA approval process for new WiSE manufacturing site","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402990","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402990?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:08","pubTimestamp":1790554084,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ). EBR Systems, developer of the WiSE wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PINK","IEIH","RSPH","IDNA","LABU","MRNX","GNMX","NVIB","TECB","EES","MEDI","FRTY","SYNB","XLVX","PSCH","BK4585","GDOC","MRNY","BMED","BBP","LFSC","IBB","TBXU","IYH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471553","title":"Incyte (INCY) Gets a Hold from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471553","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471553?lang=en_us&edition=fundamental","pubTime":"2026-09-26 20:16","pubTimestamp":1790424990,"startTime":"0","endTime":"0","summary":"Bernstein analyst Jeffrey Walch maintained a Hold rating on Incyte yesterday and set a price target of $104.00. The company’s shares closed yesterd...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/incyte-incy-gets-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/incyte-incy-gets-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4139","BK4585","INCY","BK4550","BK4588","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670427486","title":"Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (Zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva","url":"https://stock-news.laohu8.com/highlight/detail?id=2670427486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670427486?lang=en_us&edition=fundamental","pubTime":"2026-09-26 07:00","pubTimestamp":1790377200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nTUA9XLLCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","INCY","BK4139","BK4550","BK4532","BK4588","MIRM","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670424345","title":"Twist Bioscience CEO Emily M. Leproust Disposes of 5,203 Common Shares Worth $921,493.96","url":"https://stock-news.laohu8.com/highlight/detail?id=2670424345","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670424345?lang=en_us&edition=fundamental","pubTime":"2026-09-26 04:06","pubTimestamp":1790366770,"startTime":"0","endTime":"0","summary":"Twist Bioscience CEO Emily M. Leproust disposes of 5,203 common shares worth $921,493.96Twist Bioscience CEO Emily M. Leproust sold 5,203 shares of common stock on Sep. 24, 2026.Sales prices ranged fr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nNDLb8CMCK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience CEO Emily M. Leproust Disposes of 5,203 Common Shares Worth $921,493.96","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","BK4139","BK4588","IDNA","TWST","WDNA","BK4585","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670421169","title":"FDA approves Incyte’s Atebrioz for fibrodysplasia ossificans progressiva","url":"https://stock-news.laohu8.com/highlight/detail?id=2670421169","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670421169?lang=en_us&edition=fundamental","pubTime":"2026-09-26 03:00","pubTimestamp":1790362813,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration announced it has approved Atebrioz tablets to reduce the volume of total new heterotopic ossification in adul...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-incytes-atebrioz-for-fibrodysplasia-ossificans-progressiva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-incytes-atebrioz-for-fibrodysplasia-ossificans-progressiva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4532","BK4550","BK4585","BK4139","IDNA","INCY","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670542159","title":"US FDA Approves Mirum's Drug for Rare Bone Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2670542159","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670542159?lang=en_us&edition=fundamental","pubTime":"2026-09-26 02:57","pubTimestamp":1790362661,"startTime":"0","endTime":"0","summary":"US FDA approves Mirum's drug for rare bone disorderSept 25 (Reuters)-The US Food and Drug Administration has approved Mirum Pharmaceuticals'MIRM.Odrug to treat a rare bone disorder, the regulator said on Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4N45H12T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BBH","IBBQ","LU2023250504.SGD","BK4139","IBB","BK4588","LU0823434583.USD","LU0823434740.USD","TBXU","LU0320765992.SGD","BK4585","LU0889565916.HKD","LU0114720955.EUR","LU2362541513.USD","LU0058720904.USD","LU2362541273.HKD","LU0882574055.USD","LU1974910355.USD","REGN","LU0823416689.USD","LU2237438978.USD","INCY","LU2089984988.USD","BK4550","LU0289739699.SGD","LU2362540622.SGD","LU2468319806.SGD","MIRM","LU2106854487.HKD","LU1917777945.USD","BK4532","IDNA","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670421307","title":"FDA: Approves Atebrioz (Zilurgisertib) for Fibrodysplasia Ossificans Progressiva in Adults & Pediatric Patients 12 Years + - Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2670421307","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670421307?lang=en_us&edition=fundamental","pubTime":"2026-09-26 02:52","pubTimestamp":1790362346,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45H12W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4139","INCY","BK4532","BK4550","IDNA","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670300421","title":"FDA : Atebrioz Recommended Dosage 100 Mg Once Daily","url":"https://stock-news.laohu8.com/highlight/detail?id=2670300421","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670300421?lang=en_us&edition=fundamental","pubTime":"2026-09-26 02:52","pubTimestamp":1790362346,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45H12W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4550","BK4139","BK4585","IDNA","BK4588","INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670706429","title":"NASDAQ New 52-Week Highs and Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2670706429","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670706429?lang=en_us&edition=fundamental","pubTime":"2026-09-26 02:22","pubTimestamp":1790360520,"startTime":"0","endTime":"0","summary":"ARC Group Secs Acqn I        FJDIU       10.14         26,835. Gl X Genomics & Biotech      GNOM        70.83         11,765. GrShr 2x Long AMD Daily      AMDL        86.43      1,432,877. Invsc BS 2036 Mun Bd         BSMA        27.15          6,786. Leverage 2X Lg AMD Dly       AMDG       145.58         21,664","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","LU0210536198.USD","TQQY","LU2361044865.SGD","SGXZ99366536.SGD","NOCT",".HXC","SGXZ51526630.SGD","LU0274383776.USD","IE0001KFT4U8.USD","BAI","LU0081259029.USD","AMDU","LU1232071149.USD","SG9999014013.SGD","LU2458330243.SGD","NAPR","LU0708995401.HKD","LU1988902786.USD","MRNA","XNTK","LU0786609619.USD","LU1803068979.SGD","LU0823421416.USD","FTXL","LU1804176565.USD","IE00BMPRXQ63.HKD","LU2458330169.SGD","IE00BQXX3C00.GBP","LU2417539215.USD","LU2210150020.SGD","QQQM","LU0198837287.USD","LU2360107168.USD","LU0823421333.USD","CHPS","IE00BKVL7J92.USD","BK4588","LU2250418816.HKD","LU0823434583.USD","LU0109391861.USD","LU0792757196.USD","MRNY","LU0889566641.SGD","LU1880398554.USD","LU1989764748.USD","LU2242649171.HKD","LU2462591350.SGD","LU0109392836.USD","LU2456880835.USD","SGXZ81514606.USD","LU1989772923.USD","BK4543","SQQQ","IE00BMPRXN33.USD","03086","TRFK","QMAR","LU0320765059.SGD","LU0889565833.HKD","AMDD","LU2210149790.SGD","LU0133085943.USD","LU2860962120.EUR","BCDF","BK4575","LU1861215975.USD","MRNX","IE00BN0W2W23.USD","AMDC","LU1316542783.SGD","LU2931357623.SGD","LU2264538146.SGD","LU1242518857.USD","LU2461242641.AUD","LU1852331112.SGD","IE00BMPRXR70.SGD","FAI","AMYY","AMDY","GAMR","QQQ","LU2290526834.HKD","LU0174119429.USD","LU0056508442.USD","BK4529","IE0004445239.USD","LU2247934214.USD","PSQ","LU2054465674.USD","DAMD","IE00BN0W2T93.GBP","IE00B1BXHZ80.USD",".IXIC","BK4568","BK4614","LU1267930730.SGD","SMH","BK4566","LU0082616367.USD","LU0823434740.USD","LEGR","SOXY","SMHX","09086","TQQQ","IE00BZ1G4Q59.USD","PSI","LU0390134368.USD","LGHT","LU1861559042.SGD","BK4533","IE00BKPKM429.USD","LU2265009873.SGD","BK4573","TEK","BK4534","BK4141","LU1267930813.SGD","LU1923623000.USD","BK4512","LU0127658192.USD","TTEQ","LU0672654240.SGD","SG9999014021.USD","LU2095319765.USD","BK4554","LU0048584097.USD","LU1242518931.SGD","LU2543165471.USD","LU1951198990.SGD","LU0719512351.SGD","IE00BN0W2V16.EUR","LU0251132253.USD","BK4612","QID","AMDG","GPIQ","WDNA","LU2361044949.HKD","LU2896262040.SGD","IE00B64PRP62.GBP","BK4548","SOXX","NJAN","LU1064131342.USD","QLD","03455","LU0348723411.USD","BK4139","07266","IE00BQXX3F31.USD","LU2361045086.USD","LU2360106780.USD","BK4112","IE00BGHQF748.EUR","07261","WISE","09834","NDAQ","LU1989772840.SGD","LU2089985449.USD","ILDR","LU2355687059.USD","QDEC","CNAV","SG9999014039.USD","LU1861558580.USD","WUGI","LU0642271901.SGD","AMDW","IE00B3QW5Z07.USD","IETC","SG9999014005.SGD","IE00BQXX3D17.EUR","AMDL","LU1951200564.SGD","BK4501","LU1303367103.USD","LU2098885051.SGD","LU2108987350.USD","BK4585","IE00B5949003.HKD","SG9999001424.SGD","BK4605","07568","BK4532","07522","AMUU","03034","QQQX","SAMD0main","LU1989764664.SGD","IE0009356076.USD","USXF","02834","LU2236285917.USD","AIQ","LU0314104364.USD","AMD","QQQA","IDNA","LU1861220033.SGD","NDX","NJUL","GNOM","AIS","AMDS","LU1880398471.USD","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670425143","title":"Innovation is Driving a New Bull Market in Biotech. 16 Ways to Play It, from Our Roundtable Experts.","url":"https://stock-news.laohu8.com/highlight/detail?id=2670425143","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670425143?lang=en_us&edition=fundamental","pubTime":"2026-09-25 23:39","pubTimestamp":1790350740,"startTime":"0","endTime":"0","summary":"A tidal wave of innovation in biotechnology is improving patient outcomes, transforming the industry's prospects, and lifting long-suffering biotech shares. Spurred by therapeutic breakthroughs and ne","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","BK4585","FTXH","LU0289739699.SGD","IE00BLSP4239.USD","IE0002141913.USD","BK4548","IE00B2B36J28.USD","SG9999015358.SGD","LU1201861249.SGD","LU0106261372.USD","LU1035773651.USD","BK4588","LU0124676726.USD","LU1989771016.USD","LU2491050154.USD","LU1699723380.USD","LU0965508806.USD","LU2112291526.USD","LU2023250504.SGD","SG9999014567.USD","LU1929549753.HKD","LU1989772923.USD","LU1917777945.USD","BMED","SG9999014542.SGD","LU1057294990.SGD","BK4550","IE00B1BXHZ80.USD","LU2125909247.SGD","LU0289961442.SGD","GNOM","LU0648001328.SGD","LU0208291251.USD","LU1116320901.HKD","LU2357627491.SGD","LU0058720904.USD","LU0942090050.USD","LU1037948897.HKD","IYH","LU0234572021.USD","BK4568","LU1032466523.USD","LU0006306889.USD","LU1989772840.SGD","LU0965509101.SGD","LU0689626769.HKD","LU2089984988.USD","LU0980610538.SGD","LU1585245621.USD","IE00BLSP4452.SGD","SG9999013999.USD","LU1069347547.HKD","LU2360032135.SGD","IHE","MRK","LU0130102774.USD","MRNX","LU0162691827.USD","LU0122379950.USD","LU1934455194.USD","LU0211331839.USD","LU0432979614.USD","LU0823416689.USD","LU1037948541.HKD","LU0072461881.USD","JDOC","LU2461242641.AUD","LU0265550946.USD","LU0868494708.USD","LU1291159041.SGD","LU2491050071.SGD","TRUH","LU0861579265.USD","VHT","IE00BFTCPJ56.SGD","LU1066051498.USD","LU0472753341.HKD","LU0320765489.SGD","LU1093756325.SGD","LU2361044949.HKD","IE00BN8TJ469.HKD","SG9999015341.SGD","LU1023059063.AUD","LU2324357040.USD","LU0266013472.USD","LU1066051811.HKD","LU0238689110.USD","LU0985320562.USD","LU1066051225.USD","LU0265550359.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","SG9999001176.SGD","IE00BJT1NW94.SGD","LU1116320737.USD","LU1941712264.USD","LU2125154935.USD","LU2468319806.SGD","LU0965509010.AUD","LU2361045086.USD","HRTS","XBI","SGXZ57979304.SGD","LU0320765646.SGD","LU1934455863.HKD","LGHT","LU1941712348.USD","IE0009355771.USD","LU0289739343.SGD","SG9999002224.SGD","LU0098860793.USD","RXL","LU2106854487.HKD","MRNY","LU1934455277.USD","LU2023250843.SGD","SG9999001440.SGD","LU1066053197.SGD","LU1571399168.USD","LU1430594728.SGD","LU2125154778.USD","BK4551","MRNA","BK4516","LU0069063385.USD","LU0965509283.SGD","WDNA","IBB","SG9999002232.USD","LU0130517989.USD","LU2433249047.HKD","SG9999014559.SGD","LU0070302665.USD","FHLC","BK4501","BK4534","IDNA","LU1983299246.USD","PAWZ","IE00BSNM7G36.USD","IE00BBT3K403.USD","LU1061106388.HKD","BK4532","GDOC","BK4581","LU1923622614.USD","LU2125909593.SGD","LU0868494617.USD","LU1974910355.USD","LU2491049909.HKD","IXJ","BK4559","LU0511384066.AUD","LU0203345920.USD","SG9999001176.USD","BK4139","LU0203347892.USD","LU1093756168.USD","LU2361044865.SGD","IE000M9KFDE8.USD","BK4533","PPH","SG9999014575.USD","XLV","LU0859254822.USD","LU0057025933.USD","LU1162221912.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442867","title":"Moderna (MRNA) Receives a Hold from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442867?lang=en_us&edition=fundamental","pubTime":"2026-09-25 18:56","pubTimestamp":1790333800,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Hold rating on Moderna yesterday and set a price target of $45.00. The company’s shares closed yester...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/moderna-mrna-receives-a-hold-from-bernstein-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/moderna-mrna-receives-a-hold-from-bernstein-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WDNA","GNOM","BK4533","BK4548","IDNA","MRNA","MRNX","MRNY","BK4534","BK4551","BK4532","BK4568","BK4501","BK4139","BK4588","BK4585","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670445433","title":"Vertex Minerals Sets October General Meeting for Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2670445433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670445433?lang=en_us&edition=fundamental","pubTime":"2026-09-25 15:37","pubTimestamp":1790321843,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has issued an update. Vertex Minerals Ltd. is an Australian-listed resources company trading on the ASX under th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-sets-october-general-meeting-for-shareholders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-sets-october-general-meeting-for-shareholders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","LU0823416689.USD","LU0234570918.USD","BK4585","IDNA","IE00B19Z9P08.USD","IBB","IE00BZ9MQY76.HKD","BIB","PBE","LU2324357040.USD","LU1674673428.USD","LU1069344957.HKD","LU2462157665.USD","LU0320765992.SGD","SG9999001176.USD","LU2236285917.USD","VRTX","LU0061475181.USD","IE00B4R5TH58.HKD","LU1430594728.SGD","LU2362540622.SGD","MTX","GNMX","LU0889565916.HKD","LU0417517546.SGD","LU0432979614.USD","LU1035775433.USD","IE00B19Z3B42.SGD","IE0002141913.USD","LU2417539215.USD","IE0009355771.USD","LU1674673691.USD","LU1093756168.USD","IE0002270589.USD","LU0058720904.USD","LU1585245621.USD","TBXU","BBH","LU0109394709.USD","IE00B19Z9Z06.USD","BK4532","VERX","LU1559883803.SGD","BK4139","IE00BFTCPJ56.SGD","LU1093756325.SGD","IE00B894F039.SGD","SG9999001176.SGD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670417369","title":"INLIF Stock Is Trending: Here's Why it Skyrocketed Over 93% After Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2670417369","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670417369?lang=en_us&edition=fundamental","pubTime":"2026-09-25 11:49","pubTimestamp":1790308178,"startTime":"0","endTime":"0","summary":"INLIF shares soared 93% after hours Thursday following strong first-half revenue growth and a return to profitability.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/09/61988300/inlif-stock-jumps-93-percent-after-hours-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","BK4161","BK4568","BK4150","BK4532","IDNA","MRNX","RSI","MRNA","BK4585","BK4588","ODDS","MRNY","BK4533","GNOM","BETZ","BK4534","BK4551","WDNA","BK4501","INLF","BK4139","BK4548","ODDZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670415347","title":"Revolution Medicines Director Elizabeth M. Anderson Disposes of $1,949,321.86 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2670415347","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670415347?lang=en_us&edition=fundamental","pubTime":"2026-09-25 06:00","pubTimestamp":1790287241,"startTime":"0","endTime":"0","summary":"Revolution Medicines director Elizabeth M. Anderson disposes of $1,949,321.86 in common sharesElizabeth M. Anderson, director, cut her direct stake in Revolution Medicines common stock to 4,333 shares","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL3Nb1nM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Director Elizabeth M. Anderson Disposes of $1,949,321.86 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00B4R5TH58.HKD","BK4139","BBH","LU0109394709.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE0009354923.USD","IE00B2B36J28.USD","CANC","PTH","LU0320765992.SGD","RVMD","IE0002141913.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670184794","title":"Moderna Inc. Stock Advances 7.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2670184794","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670184794?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:33","pubTimestamp":1790281980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 7.0% to $194.82 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 26,939.37 and the Dow Jones Industrial Average falling 0.3% to 51,349.98.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $192.31, which the company reached on September 23rd.The stock outperformed some of its peers, as Johnson & Johnson rose 0.6% to $270.68, Pfizer Inc. rose 0.8% to $28.41, and Gilead Sciences Inc. fell 1.11% to $149.69.Trading volume totaled 16.4 million, compared to the 50-day average of 18.6 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509101.SGD","LU1674673428.USD","TBXU","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU2468319806.SGD","IE00B19Z3B42.SGD","IBB","MRNY","LU2324357040.USD","LU0234570918.USD","LU0289739699.SGD","LU2112291526.USD","LGHT","WDNA","BBH","GNOM","SG9999015952.SGD","LU0965508806.USD","LU0965509010.AUD","IE00B3T34201.USD","BK4550","IE00BKVL7J92.USD","BK4534","BK4551","MRNX","BK4568","BMED","IE00B19Z3581.USD","LU1430594728.SGD","IE0002270589.USD","LU1571399168.USD","IBBQ","LU0861579265.USD","LU0965509283.SGD","LU1066053197.SGD","LU1057294990.SGD","LU1061106388.HKD","BK4532","LU2357627491.SGD","LU1934455863.HKD","MEDI","LU0859254822.USD","TMED","BIB","BK4533","IDNA","MRNA","GILD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670909974","title":"Moderna Inc Stock (MRNA) Moved Up by 5.91% on Sep 24: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2670909974","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670909974?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:15","pubTimestamp":1790277319,"startTime":"0","endTime":"0","summary":"• Moderna shares rose as investors welcomed its transformation into a diversified biotechnology platform.\n• Anticipation for Phase 3 oncology trial data and new respiratory approvals drove buying pressure.\n• The company reported $1.94 billion in annual revenue and a net loss.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262185597-market-movers-mrna-20260924","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","LGHT","BK4532","BK4501","BK4588","WDNA","BK4551","MRNA","MRNX","BK4548","BK4568","BK4533","BK4585","GNOM","MRNY","BK4139","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669496278","title":"Twist Bioscience Corp Stock (TWST) Moved Up by 11.04% on Sep 24: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669496278","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669496278?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:15","pubTimestamp":1790259319,"startTime":"0","endTime":"0","summary":"• Twist partnered with Eli Lilly to integrate data into TuneLab.\n• Third-quarter results showed double-digit revenue growth and improved margins.\n• Annual revenue reached $376.57M alongside a net loss of $77.67M.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262185189-market-movers-twst-20260924","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","WDNA","BK4585","BK4588","IDNA","BK4139","TWST","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669446047","title":"U.S. Stocks on the MOVE-Everpure, Dropbox, Darden Restaurants","url":"https://stock-news.laohu8.com/highlight/detail?id=2669446047","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669446047?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:12","pubTimestamp":1790251979,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Everpure, Dropbox, Darden RestaurantsSeptember 24 (Reuters)-Wall Street futures dropped on Thursday as the Middle East conflict remained far from a resolution, while inves","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL6N45G0Q9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JOUL","TLTW","LU2394011477.USD","DRI","LU0154245756.USD","BK4504","BK4598","LU0957808578.USD","BK4585","BK4567","TBJL","DBX","BK4581","LU2065171311.SGD","LU1642822529.SGD","GNOM","BBSB","ISHG","TFJL","BK4023","LU2237438978.USD","BK4129","BBLB","BWX","TSYW","SFIX","TWST","TLT","HWAY","LU2265009873.SGD","THNR","IEF","BK4532","BK4139","BWZ","LU0444971666.USD","LU1571399168.USD","LU0323239441.USD","BK4599","SHV","LU1093756325.SGD","SHY","MGM","BK4170","IGOV","ZAP","LU1093756168.USD","P","LU2065169927.USD","LU2106854487.HKD","TLH","ODDZ","SG9999001440.SGD","LU2065170008.USD","LU0353189763.USD","POWR","VKTX","BK4534","BK4528","KYTX","LU2087625088.SGD","ARKG","BK4094","TLTI","BK4588","BK4209","LU0154245673.USD","WDNA","BK4551","LU2023250504.SGD","GRML","GRID","LU2023250843.SGD","OZEM","BK4150","LU1815336760.USD","LU1261432733.SGD","BK4561","BBIB","PWR","LU1804176565.USD","FLGV","LU1917777945.USD","POW","LU1974910355.USD","IDNA","SGOV","LU0323240290.USD","ACAD","LU0353189680.USD","TLTX","BK4122","IEI","PUL","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669934134","title":"Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2669934134","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669934134?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251200,"startTime":"0","endTime":"0","summary":"Montreal Heart Institute Joins Multinational Study Evaluating a Self-Administered 70 mg Repeat-Dose Regimen of EtripamilMONTREAL and CHARLOTTE, N.C., Sept.  24, 2026 (GLOBE NEWSWIRE) -- Milestone Phar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368250/0/en/milestone-pharmaceuticals-enrolls-first-canadian-study-participant-in-revera-301-phase-3-pivotal-trial-evaluating-etripamil-nasal-spray-for-afib-rvr.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","MEDX","HYLG","BK4588","AV","LU0566484027.USD","ECG","VR","BK4129","BK4585","LU1559883803.SGD","LABU","IDNA","NVIB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}